Skin Care Carries J&J Consumer Biz. In Quarter Marred By OTC Drug Recall
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson's skin-care franchise helped offset weak oral-care sales and hampered over-the-counter and nutritionals business associated with a recall of Motrin, Tylenol and other products in the firm's fiscal 2010 first quarter